N-Zyme Biomedical Secures $4.6 Million Series A Financing to Advance Phase 2 Clinical Programs for Novel Reflux Disease Therapy N-Zyme Biomedical has successfully completed its Series A financing round, raising…
bioAffinity Technologies and Pictor Partner to Advance Next-Generation Precision Diagnostics for Asthma and COPD bioAffinity Technologies, Inc., a biotechnology company focused on developing innovative cancer diagnostics and targeted therapeutics, has…
Arrowhead Pharmaceuticals Reports Positive Phase 3 Results for Plozasiran in Severe Hypertriglyceridemia, Demonstrating Significant Triglyceride Reduction and Lower Risk of Acute Pancreatitis Arrowhead Pharmaceuticals, Inc. has announced positive topline results…
Zoetis Launches Portela® in Canada and Europe, Introducing the First Long-Acting Anti-NGF Therapy for Feline Osteoarthritis Pain Zoetis Inc. has announced the commercial launch of Portela® (relfovetmab) across Canada and…
Johnson & Johnson Receives FDA De Novo Authorization for OTTAVA™ Robotic Surgical System, Marking a New Era in Robotic-Assisted Surgery Johnson & Johnson has achieved a major milestone in the…
Crysvita® Approved Across the EU for Infants Living with X-Linked Hypophosphataemia Kyowa Kirin EMEA, a wholly owned subsidiary of Kyowa Kirin Co., Ltd., has announced that the European Commission (EC)…
The BRAIN Foundation and Stanford Medicine Launch Aurora Research Network to Advance Evidence-Based Care for Severe Neuropsychiatric Deterioration The BRAIN Foundation, in partnership with Stanford Medicine, has announced the launch…
Seek Labs Publishes Nature Communications Study Showcasing ANINA™ Technology for Next-Generation Molecular Diagnostics Seek Labs, a private TechBio company focused on developing programmable technologies to decode, understand, and treat disease,…
FUJIFILM Sonosite Launches Sonosite iLOOK, a Dedicated Ultrasound Solution Designed to Enhance Vascular Access Procedures FUJIFILM Sonosite, Inc., a global leader in point-of-care ultrasound (POCUS) technology, has announced the introduction…
Cellares and Papillon Therapeutics Partner to Automate Manufacturing of PPL-001 Gene-Edited Cell Therapy for Friedreich’s Ataxia Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO) dedicated to advancing cell…
Teleflex Awarded National Group Purchasing Agreement with Premier to Expand Access to Advanced Vascular Access Solutions Teleflex Incorporated, a global provider of medical technologies designed to improve patient care and…
Pilatus Biosciences Receives Hong Kong Clinical Trial Authorization for PLT012 and Expands Asia-Pacific Presence with New Regional Subsidiary Pilatus Biosciences, Inc., a clinical-stage biopharmaceutical company focused on developing innovative metabolic…